Navigation Links
ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
Date:3/3/2009

are; line-height:1.5em; list-style-image: url(/images_v4/bullet_solid2.gif);">
  • Aggregate multiple studies into a program/portfolio view or long-range plan
  • Generate comprehensive monthly budget, resource, and timeline reports
  • Add or remove studies from a portfolio
  • Modify study start dates
  • Adjust study probabilities

  • "ClearTrial Portfolio Planning gives life sciences companies a lightning-fast and more informed portfolio and program decision-making capability that presents a major competitive advantage, especially in today's economic climate," noted Mike Soenen, Managing Partner of ClearTrial. "The pressure to move faster with fewer resources has never been greater and with Portfolio Planning, ClearTrial is again first in class to answer that challenge."

    Key Benefits of ClearTrial Portfolio Planning
    For clinical operations, outsourcing, finance, and project/resource management professionals at life sciences organizations, ClearTrial Portfolio Planning offers:

    Integrated Roll-up for Increased Accuracy and Speed - The software eliminates errors in the time-consuming re-keying involved with manually rolling up multiple study plans into program- or company-wide forecasts. ClearTrial Portfolio Planning also ensures that planners are using the most current information by automatically updating the portfolio forecast with any changes made to the protocol-level assumptions.

    Effortless Cost and Resource Demand Forecasting Across the Organization - Monthly cost and resource demand forecasts enable companies to easily identify areas of heavy FTE utilization, and more proactively hire or contract for additional resources - or modify study start dates to smooth out resource utilization. Planners can instantly see the budget and resource impact of dropping or delaying a study or group of studies, immediately assess the result on hours and fees, by month, of outsourcing al
    '/>"/>

    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
    2. Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimers Disease
    3. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
    4. EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
    5. Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement
    6. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
    7. BioSpace.com Launches a New Season of Industry Career Fairs
    8. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
    9. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
    10. Cephalons New Product Launches Pace Record 2008 Sales
    11. BioComp Pharma Launches First Generic Drug for Tindamax(R)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/27/2014)... , November 27, 2014 ... the management of tooth decay, today announces that ... its Calcivis® Caries Activity Imaging System. ... sophisticated medical device and consumable combination designed to ... (tooth decay). It involves a unique, proprietary bioluminescence ...
    (Date:11/26/2014)... 2014 Deep Research Report on ... in-depth research report on the Ammonium Bifluoride market, ... classification, application, and industry chain structure as well ... market analysis, including China’s domestic market as well ... China, Japan etc. regions) industry analysis covering macroeconomic ...
    (Date:11/26/2014)... and PHILADELPHIA , Nov. ... most demanding and unforgiving environments. Human exploration of space ... performance to ensure mission safety and success, and prevent ... performance for mission success, little is known about how ... of cognition are primarily affected. Now, Penn ...
    (Date:11/26/2014)... (PRWEB) November 26, 2014 PMG Research, ... Board. PMG Research is a network of sites that provide ... to over 2 million patient lives through its partnerships with ... comprised of 11 hub site locations in the Southeastern United ... first term of the board will be held ...
    Breaking Biology Technology:Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 2Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 4PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3
    ... 1:30 p.m. Eastern Time Today, GAITHERSBURG, Md., March ... financial results and corporate progress for,the full year ended ... we have further demonstrated that Iomai,s,vaccine and immunostimulant patches ... president and chief executive officer,of Iomai. "This lays the ...
    ... HILLS, Mass., March 6 Joseph F. Finn, ... of ActivBiotics, announced,today that the Office of Orphan ... has granted Orphan Drug Designation for M40403 for ... oral mucositis (OM),in cancer patients., The development ...
    ... EntreMed, Inc.,(Nasdaq: ENMD ), a clinical-stage pharmaceutical ... inflammatory diseases, today,reported results for the three months ... http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO ), For fiscal year ... 2006. For the year ended December 31, 2007, ...
    Cached Biology Technology:Iomai Announces Year-End 2007 Financial Results and Business Progress 2Iomai Announces Year-End 2007 Financial Results and Business Progress 3Iomai Announces Year-End 2007 Financial Results and Business Progress 4Iomai Announces Year-End 2007 Financial Results and Business Progress 5Iomai Announces Year-End 2007 Financial Results and Business Progress 6ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis of Cancer 2ActivBiotics Receives FDA Orphan Drug Designation for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis of Cancer 3EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results 2EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results 3EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results 4EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results 5
    (Date:11/11/2014)... CHICAGO , Nov. 11, 2014  Forensicon, Inc., ... eDiscovery firm, is pleased to announce the promotion of ... to Director of Digital Forensics. In Schiff,s new role ... out the team of digital forensics examiners and provide ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 ...
    (Date:11/7/2014)... -- Leading Biometric companies aim to provide consumers ... transactions.  Companies in focus today are: NXT-ID, Inc. (NASDAQ: ... ), Google Inc. (NASDAQ: GOOG ), Microsoft Corporation ... EBAY ) and MasterCard Inc. (NYSE: MA) NXT-ID, ... authentication company focused on the growing mobile commerce is pleased ...
    (Date:11/6/2014)... - Insilico Medicine, Inc, a Baltimore-based bioinformatics company ... diseases announced a research collaboration with the international ... Inc (OTC: CSBR). , "There are many companies ... Champions Oncology,s TumorGraft technology is unique in a ... experimentally generating vast amounts of valuable data. Our ...
    Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
    ... And to survive, such marine predators need to sustain the right ... a new study by researchers from the University of British Columbia ... the online journal PLOS ONE , the study is the ... on the quality of their diets and this plays an important ...
    ... researchers, led by Dr. Frdric Charron, recently uncovered a ... discovery was made in collaboration with Dr. Alyson Fournier,s ... the prestigious scientific journal Neuron , this breakthrough ... repair and regenerate nerve cells following injuries to the ...
    ... are capped at their ends with special DNA structures ... act as a protective sheath. Telomeres are maintained through ... proteins. Researchers at The Wistar Institute have defined the ... Understanding how telomeres keep chromosomes and by ...
    Cached Biology News:A step forward in regenerating and repairing damaged nerve cells 2It takes two to tangle: Wistar scientists further unravel telomere biology 2
    Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
    Arginine vasopressin receptor (AVP-V2), rat. The peptide used for immunization has no significant similarity with AVP V1a or V1b receptors....
    ... WinList come straight from the folks who ... automatic region positioning, N-Stat regions, and presentation-quality ... thoughtful conversations, and careful design. Of course, ... are still there, too. WinList leads the ...
    Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
    Biology Products: